Latest News and Press Releases

Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Competition Law for the Pharmaceutical Industry Training Course" training has been added to ResearchAndMarkets.com's offering. This comprehensive...

– New patent enhances market position in Europe HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical...

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Blockbuster Drugs on Patent Cliffs" report has been added to ResearchAndMarkets.com's offering. This report talks about the effect of patent cliffs...

Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Africa Pharmaceuticals Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application,...

PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a...

Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "Canada Pharmaceutical Market Size, Share & Trends Analysis Report by Drug Type, Product (Branded), Type (Prescription, OTC), Disease (Cancer),...

PASADENA, CALIF, July 02, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a...

Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer  FDA recommends inclusion of patients as young as 6 months – younger than...

Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Sales Outsourcing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...

Access the on-demand webcast here HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad...